Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
13.74
-0.08 (-0.58%)
May 14, 2025, 2:13 PM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Dermatological Treatments
196.54M
Log In
Log In
Dermatological Treatments Growth
229.74%
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
United States and Canada
196.54M
Log In
Log In
United States and Canada Growth
229.74%
Log In
Log In
United States
-
Log In
Log In